OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BRIL55

Black Rose Industries Ltd

Specialty ChemicalsVerified

Black Rose Industries Ltd maintains a strong liquidity position, with a current ratio of 3.48, indicating the company can easily cover its short-term liabilities with its short-term assets. The company also holds INR 186.48 million in cash and equivalents, which provides a buffer against short-term financial pressures. The debt-to-equity ratio is 0.03, suggesting a conservative capital structure with minimal reliance on debt financing. In terms of profitability, the company's return on equity (ROE) is 3.93%, and its return on assets (ROA) is 2.96%. These figures are below the typical thresholds for high-performing specialty chemical firms, indicating that the company is generating modest returns relative to its equity and asset base. The operating margin is 5.54% (calculated from operating income of INR 63.86 million on revenue of INR 1.15 billion), which is in line with the industry's median for firms of similar scale. The company's revenue is concentrated in a single business segment, as no segmental breakdown is disclosed in the available data. Geographically, the firm's exposure is not explicitly detailed, but the absence of segmental or geographic diversification suggests a potential concentration risk. Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. The capital expenditure of INR -29.89 million indicates a net outflow for the period, which may reflect ongoing investments in infrastructure or equipment. However, the absence of a clear growth strategy or expansion plans in the available data suggests limited visibility into future revenue drivers. The risk assessment indicates a low probability of dilution and no immediate liquidity concerns. The company has not issued additional shares in the recent period, and there are no signs of pressure to raise capital through equity issuance. The absence of filing-based flags further supports the conclusion that the company is not currently facing material financial distress or governance issues. No recent filings or transcripts are available to provide insight into the company's strategic direction or operational performance. The lack of recent disclosures limits the ability to assess any material changes in the company's business model or market position.

30-day price · BRIL+14.30 (+19.7%)
Low$61.00High$92.93Close$87.03As of13 May, 00:00 UTC
Profile
CompanyBlack Rose Industries Ltd
TickerBRIL.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Black Rose Industries Ltd is a specialty chemicals company that generates revenue primarily through the production and distribution of chemical products.

Classification. Black Rose Industries Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Black Rose Industries Ltd maintains a strong liquidity position, with a current ratio of 3.48, indicating the company can easily cover its short-term liabilities with its short-term assets. The company also holds INR 186.48 million in cash and equivalents, which provides a buffer against short-term financial pressures. The debt-to-equity ratio is 0.03, suggesting a conservative capital structure with minimal reliance on debt financing. In terms of profitability, the company's return on equity (ROE) is 3.93%, and its return on assets (ROA) is 2.96%. These figures are below the typical thresholds for high-performing specialty chemical firms, indicating that the company is generating modest returns relative to its equity and asset base. The operating margin is 5.54% (calculated from operating income of INR 63.86 million on revenue of INR 1.15 billion), which is in line with the industry's median for firms of similar scale. The company's revenue is concentrated in a single business segment, as no segmental breakdown is disclosed in the available data. Geographically, the firm's exposure is not explicitly detailed, but the absence of segmental or geographic diversification suggests a potential concentration risk. Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. The capital expenditure of INR -29.89 million indicates a net outflow for the period, which may reflect ongoing investments in infrastructure or equipment. However, the absence of a clear growth strategy or expansion plans in the available data suggests limited visibility into future revenue drivers. The risk assessment indicates a low probability of dilution and no immediate liquidity concerns. The company has not issued additional shares in the recent period, and there are no signs of pressure to raise capital through equity issuance. The absence of filing-based flags further supports the conclusion that the company is not currently facing material financial distress or governance issues. No recent filings or transcripts are available to provide insight into the company's strategic direction or operational performance. The lack of recent disclosures limits the ability to assess any material changes in the company's business model or market position.
Key takeaways
  • Black Rose Industries Ltd maintains a strong liquidity position with a current ratio of 3.48 and INR 186.48 million in cash and equivalents.
  • The company's return on equity and return on assets are modest, at 3.93% and 2.96%, respectively, indicating limited profitability relative to its equity and asset base.
  • The company's capital structure is conservative, with a debt-to-equity ratio of 0.03, and no immediate liquidity or dilution risks are identified.
  • The absence of segmental or geographic diversification suggests a potential concentration risk, though the company's financials remain stable.
  • No recent filings or transcripts are available, limiting visibility into the company's strategic direction or operational performance.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$1.15B
Gross profit$186.2M
Operating income$63.9M
Net income$57.0M
R&D
SG&A
D&A
SBC
Operating cash flow$168.0M
CapEx-$29.9M
Free cash flow
Total assets$1.93B
Total liabilities$474.5M
Total equity$1.45B
Cash & equivalents$186.5M
Long-term debt$42.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$3.80B$372.7M$274.4M$240.4M
FY-3$4.86B$413.4M$319.0M$280.8M
FY-2$4.30B$109.6M$79.2M$53.5M
FY-1$3.80B$250.2M$212.3M$184.4M
FY0$3.91B$258.3M$209.4M$71.4M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$1.47B$929.9M$78.4M
FY-3$1.76B$1.22B$87.2M
FY-2$1.62B$1.27B$88.1M
FY-1$1.93B$1.45B$105.8M
FY0$2.14B$1.53B$19.7M
PeriodOCFCapExFCFSBC
FY-4$103.4M-$59.8M$240.4M
FY-3$146.8M-$64.3M$280.8M
FY-2$224.7M-$56.1M$53.5M
FY-1$168.0M-$29.9M$184.4M
FY0-$125.1M-$34.4M$71.4M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$1.15B$63.9M$57.0M
FQ-6$982.7M$54.1M$47.2M
FQ-5$930.5M$58.2M$47.1M
FQ-4$877.0M$72.8M$57.0M
FQ-3$828.9M$75.0M$58.1M
FQ-2$598.5M$49.0M$41.9M
FQ-1$839.8M$62.6M$44.3M
FQ0$751.5M$55.3M$44.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.93B$1.45B$186.5M
FQ-6
FQ-5$1.90B$1.41B$133.6M
FQ-4
FQ-3$2.14B$1.53B$90.8M
FQ-2
FQ-1$2.13B$1.56B$98.6M
FQ0
PeriodOCFCapExFCFSBC
FQ-7$168.0M-$29.9M
FQ-6
FQ-5-$198.8M-$11.2M
FQ-4
FQ-3-$125.1M-$34.4M
FQ-2
FQ-1$210.6M-$37.7M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.45B
Net cash$144.2M
Current ratio3.5
Debt/Equity0.0
ROA3.0%
ROE3.9%
Cash conversion3.0%
CapEx/Revenue-2.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricBRILActivity
Op margin5.5%5.5% medp25 -0.0% · p75 10.8%above median
Net margin4.9%4.1% medp25 0.1% · p75 8.8%above median
Gross margin16.1%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-2.6%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity3.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:03 UTC#e8f851ec
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 13:31 UTCJob: eae6cf61